Private Advisor Group LLC Purchases 25,964 Shares of IperionX Limited Sponsored ADR $IPX

Private Advisor Group LLC boosted its holdings in shares of IperionX Limited Sponsored ADR (NASDAQ:IPX) by 69.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 63,111 shares of the company’s stock after purchasing an additional 25,964 shares during the quarter. Private Advisor Group LLC owned about 0.19% of IperionX worth $1,643,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the business. Van ECK Associates Corp increased its holdings in shares of IperionX by 61.0% during the 4th quarter. Van ECK Associates Corp now owns 1,337,343 shares of the company’s stock worth $48,392,000 after purchasing an additional 506,612 shares during the period. Jane Street Group LLC raised its position in IperionX by 62.5% in the fourth quarter. Jane Street Group LLC now owns 129,020 shares of the company’s stock worth $4,669,000 after purchasing an additional 49,645 shares in the last quarter. Millennium Management LLC acquired a new position in shares of IperionX in the 4th quarter worth approximately $4,249,000. Bank of America Corp DE raised its stake in IperionX by 69.0% during the second quarter. Bank of America Corp DE now owns 35,441 shares of the company’s stock worth $1,116,000 after acquiring an additional 14,467 shares in the last quarter. Finally, Quadrature Capital Ltd grew its holdings in shares of IperionX by 42.8% in the 4th quarter. Quadrature Capital Ltd now owns 14,918 shares of the company’s stock worth $540,000 after purchasing an additional 4,471 shares during the last quarter. 2.76% of the stock is owned by institutional investors.

IperionX Price Performance

IPX traded up $1.28 on Friday, reaching $25.03. The company had a trading volume of 375,703 shares, compared to its average volume of 339,778. IperionX Limited Sponsored ADR has a fifty-two week low of $21.66 and a fifty-two week high of $61.45. The company’s fifty day moving average is $34.28 and its 200 day moving average is $37.48. The company has a quick ratio of 4.00, a current ratio of 4.03 and a debt-to-equity ratio of 0.03.

Insider Buying and Selling at IperionX

In other news, CEO Anastasios Arima bought 110,000 shares of the company’s stock in a transaction dated Tuesday, April 28th. The stock was bought at an average price of $4.49 per share, with a total value of $493,900.00. Following the completion of the acquisition, the chief executive officer owned 12,316,782 shares of the company’s stock, valued at $55,302,351.18. This represents a 0.90% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, Chairman Todd Hannigan bought 260,000 shares of IperionX stock in a transaction dated Wednesday, April 29th. The stock was acquired at an average cost of $4.20 per share, with a total value of $1,092,000.00. Following the transaction, the chairman owned 26,108,334 shares of the company’s stock, valued at $109,655,002.80. This trade represents a 1.01% increase in their position. The SEC filing for this purchase provides additional information. Insiders have acquired a total of 590,000 shares of company stock worth $2,571,500 in the last quarter.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on IPX shares. Roth Capital reaffirmed a “buy” rating on shares of IperionX in a report on Monday, June 8th. Alliance Global Partners reaffirmed a “buy” rating on shares of IperionX in a research note on Tuesday, April 28th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of IperionX in a research note on Tuesday, April 21st. Finally, BTIG Research lifted their price target on IperionX from $40.00 to $55.00 and gave the company a “buy” rating in a research note on Friday, June 5th. Five analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $60.33.

IperionX Profile

IperionX (NASDAQ: IPX) is a mineral technology company focused on the production and commercialization of high‐purity titanium and zirconium products. The company’s core activities include the development of advanced mineral sands projects and the deployment of proprietary processing technologies aimed at supplying feedstocks to aerospace, defense, additive manufacturing and battery markets.

At the heart of IperionX’s operations is the Stony Creek Project in Virginia, where the company holds significant mineral sands rights.